New Peptide-Drug Conjugates for Precise Targeting of SORT1-Mediated Vasculogenic Mimicry in the Tumor Microenvironment of TNBC-Derived MDA-MB-231 Breast and Ovarian ES-2 Clear Cell Carcinoma Cells

Cyndia Charfi(Theratechnologies (Canada)), Borhane Annabi(Université du Québec à Montréal)

Frontiers in Oncology

October 22, 2021

10.3389/fonc.2021.760787

Cited by 26

Related Papers

Evidence for Transcriptional Regulation of the Glucose-6-Phosphate Transporter by HIF-1<i>α</i>: Targeting G6PT with Mumbaistatin Analogs in Hypoxic Mesenchymal Stromal Cells

|Stem Cells|2008|53

EGCG Prevents the Onset of an Inflammatory and Cancer-Associated Adipocyte-like Phenotype in Adipose-Derived Mesenchymal Stem/Stromal Cells in Response to the Triple-Negative Breast Cancer Secretome

|Nutrients|2022|40

A prostate secretory protein94‐derived synthetic peptide PCK3145 inhibits VEGF signalling in endothelial cells: Implication in tumor angiogenesis

|International Journal of Cancer|2005|36

MT1-MMP Cooperates with TGF-β Receptor-Mediated Signaling to Trigger SNAIL and Induce Epithelial-to-Mesenchymal-like Transition in U87 Glioblastoma Cells

|International Journal of Molecular Sciences|2021|35

Periostin, a signal transduction intermediate in TGF-β-induced EMT in U-87MG human glioblastoma cells, and its inhibition by anthocyanidins

|Oncotarget|2018|27